Initials DC and he's leaving office.
Moves and Counter moves?
There is no DC? Corrupt.
Moving to new post? New Formation?
Initials DC and he's leaving office.
Moves and Counter moves?
There is no DC? Corrupt.
Moving to new post? New Formation?
Go away Elon. Or is it McAfee?
Sure a lot of 6's.
Looks just like Mars CA High Desert…
NASA's Mars helicopter's third flight goes farther, faster than before
NASA's mini helicopter Ingenuity on Sunday successfully completed its third flight on Mars, moving farther and faster than ever before, with a peak speed of6.6feet per second.
After two initial flights during which the craft hovered above the Red Planet's surface, the helicopter on this third flight covered 64 feet (50 meters) of distance, reaching the speed of6.6feet per second (two meters per second), or four miles per hour in this latest flight.
"Today's flight was what we planned for, and yet it was nothing short of amazing," said Dave Lavery, the Ingenuity project's program executive.
The Perseverance rover, which carried the four-pound (1.8 kilograms) rotorcraft to Mars, filmed the 80-second third flight. NASA said Sunday that video clips would be sent to Earth in the coming days.
The lateral flight was a test for the helicopter's autonomous navigation system, which completes the route according to information received beforehand.
"If Ingenuity flies too fast, the flight algorithm can't track surface features," NASA explained in a statement about the flight.
Ingenuity's flights are challenging because of conditions vastly different from Earth's – foremost among them a rarefied atmosphere that has less than one percent the density of our own.
This means that Ingenuity's rotors, which span four feet, have to spin at 2,400 revolutions per minute to achieve lift – about five times more than a helicopter on Earth.
NASA announced it is now preparing for a fourth flight. Each flight is planned to be of increasing difficulty in order to push Ingenuity to its limits.
The Ingenuity experiment will end in one month in order to let Perseverance return to its main task: searching for signs of past microbial life on Mars.
https://www.yahoo.com/news/nasas-mars-helicopters-third-flight-180052312.html
Yeah, no.
It's the shillbots. Been part of their bs the whole time, along with the porn/tits sect.
Every time they post, a sheep somewhere wakes up.
> IG Farben
Interesting dig. Haven't found the link yet to Moderna. Bayer? That one J&J jerk was saying the Vax is as safe as ASPRIN?
Interessengemeinschaft Farbenindustrie AG (German for Dye industry syndicate corporation), commonly known as IG Farben (German for "IG Color"), was a German chemical and pharmaceutical conglomerate. Formed in 1925 from a merger of six chemical companies—BASF, Bayer, Hoechst, Agfa, Chemische Fabrik Griesheim-Elektron, and Chemische Fabrik vorm. Weiler Ter Meer[1]—it was seized by the Allies after World War II and divided back into its constituent companies.[a]
In its heyday, IG Farben was the largest company in Europe and the largest chemical and pharmaceutical company in the world.[4] IG Farben scientists made fundamental contributions to all areas of chemistry and the pharmaceutical industry. Otto Bayer discovered the polyaddition for the synthesis of polyurethane in 1937,[5] and three company scientists became Nobel laureates: Carl Bosch and Friedrich Bergius in 1931 "for their contributions to the invention and development of chemical high pressure methods",[6] and Gerhard Domagk in 1939 "for the discovery of the antibacterial effects of prontosil".[7]
The company had ties in the 1920s to the liberal German People's Party and was accused by the Nazis of being an "international capitalist Jewish company".[8] A decade later, it was a Nazi Party donor and, after the Nazi takeover of Germany in 1933, a major government contractor, providing significant material for the German war effort. Throughout that decade it purged itself of its Jewish employees; the remainder left in 1938.[9] Described as "the most notorious German industrial concern during the Third Reich"[10] in the 1940s the company relied on slave labour from concentration camps, including 30,000 from Auschwitz,[11] and was involved in medical experiments on inmates at both Auschwitz and the Mauthausen concentration camp.[12][13] One of its subsidiaries supplied the poison gas, Zyklon B, that killed over one million people in gas chambers during the Holocaust.[b][15]
The Allies seized the company at the end of the war in 1945[a] and the US authorities put its directors on trial. Held from 1947 to 1948 as one of the subsequent Nuremberg trials, the IG Farben trial saw 23 IG Farben directors tried for war crimes and 13 convicted.[16] By 1951 all had been released by the American high commissioner for Germany, John J. McCloy.[17] What remained of IG Farben in the West was split in 1951 into its six constituent companies, then again into three: BASF, Bayer and Hoechst.[a] These companies continued to operate as an informal cartel and played a major role in the West German Wirtschaftswunder. Following several later mergers the main successor companies are Agfa, BASF, Bayer and Sanofi. In 2004 the University of Frankfurt, housed in the former IG Farben head office, set up a permanent exhibition on campus, the Norbert Wollheim memorial, for the slave labourers and those killed by Zyklon B.[18]
more
https://en.wikipedia.org/wiki/IG_Farben
>Moderna vaccine manufactured in Europe
Recent article.
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna Share
News 23/04/2021
EMA’s human medicines committee (CHMP) has adopted two important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
Scaled-up processes for BioNTech/Pfizer’s COVID-19 vaccine
EMA has approved an increase in batch size and associated process scale up at Pfizer’s vaccine manufacturing site in Puurs, Belgium. The recommendation by the Agency’s Committee for Human Medicines (CHMP) is expected to have a significant impact on the supply of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, in the European Union.
Based on the review of the data submitted by BioNTech Manufacturing GmbH, the application to increase the batch size of the finished product manufactured at the Puurs site has been approved. EMA’s decision reaffirms that the Puurs facility is capable of consistently producing high-quality vaccines and enables Pfizer/BioNTech to scale up the production process at this site.
The changes described will be included in the publicly available information on this vaccine on EMA’s website.
New filling manufacturing line for COVID-19 vaccine Moderna
The CHMP also recommended the approval of a new filling line at Moderna’s finished product manufacturing site for the EU in Rovi, Spain. The new line will enable an increase in finished product fill activities, to synchronize with the active substance scale-up process at the active substance manufacturing site (Lonza, Visp) approved last month.
The changes described will be included in the publicly available information on this vaccine on EMA’s website.
EMA is in continuous dialogue with all marketing authorisation holders of COVID-19 vaccines as they seek to expand their production capacity for the supply of vaccines in the EU. The Agency provides guidance and advice on the evidence required to support and expedite applications to add new sites or increase the capacity of existing sites for the manufacture of high-quality COVID-19 vaccines.
https://www.ema.europa.eu/en/news/increase-vaccine-manufacturing-capacity-supply-covid-19-vaccines-biontechpfizer-moderna
In 1850, an upstate New York farmer named “Old Bill” Rockefeller moved to Cleveland, listed himself as a “physician” in the city directory and began to palm off bottled raw petroleum on the yokels as a cure for cancer. Calling it “Nujol” (“new oil”), it was the beginning of the Rockefeller medicine and energy monopoly – a mega-cartel that truly began when Bill’s cunning and determined son John tried his hand at selling oil. (4)
In 1856, just six years after “Old Bill” began to play doctor, an 18-year-old English chemistry student named William Henry Perkin stumbled upon a process to make purple dye from coal tar. Until then, all dyes were made from natural sources such as insects, barks, flowers, berries, animal organs and eggs. German chemists eventually made the connection between the mountains of coal tar left over from massive steel production in the Ruhr, and the new, cheaper way to make the costly dyes. Three companies emerged and dominated the new German dye industry – Hoechst, Bayer, and BASF. (5)
In 1916, Bayer chemist Carl Duisberg would organize a loose association of the eight biggest German chemical companies, and formalize this association in 1925, joining with their Swiss counterparts Ciba, Geigy and Sandoz in 1929. (6) From the beginning, the association was called the “Interessen Gemeinschaft der Deutschen Teerfarbenindustrie” – the “Community of Interest of the German Dyestuff Industry” – I.G. Farben for short.
The most richly endowed research center – the Rockefeller Institute for Medical Research – was established in New York in 1902. By 1928 it had received from John D. $65 million in endowment funds. In contrast, as late as 1938, as little as $2.8 million in federal funding was budgeted for the entire U.S. Public Health Service. (13) By 1929, the Rockefeller Foundation, first created in 1909, had received $300 million. (14)
“Eugenics” or “good genes” was a science based on “social Darwinism” or “survival of the fittest” applied to humans. It was very popular with those who had most of the wealth and felt like they needed a scientific rationale for it – to validate the great poverty and suffering that also would occur. After 1900, Rockefeller, along with the Harriman family – the family that gave theBush familyit’s start – began to spend million on “eugenics” research. (15)
So much more in this…
DIG
https://www.cannabisculture.com/content/2003/03/01/3292/